Revenue: The sum of all revenue fields included for a company's operating activities.
Seres Therapeutics, Inc. (MCRB) Revenue data is not available for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
-- |
$0.14M |
|
-- |
|
-- |
|
$121.31M |
|
$-121.31M |
|
$-4.46M |
|
$-125.77M |
|
$-125.77M |
|
$-125.77M |
|
$-125.77M |
|
$0.14M |
|
$-125.77M |
|
$-121.31M |
|
$-114.43M |
|
7.77M |
|
7.77M |
|
$0.00 |
|
$0.00 |
|
| Balance Sheet Financials | |
$38.67M |
|
$11.53M |
|
$101.14M |
|
$139.81M |
|
$41.22M |
|
-- |
|
$84.80M |
|
$126.03M |
|
$13.78M |
|
$13.78M |
|
$13.78M |
|
8.65M |
|
| Cash Flow Statement Financials | |
$-148.61M |
|
$142.29M |
|
$-90.37M |
|
$136.15M |
|
$39.46M |
|
$-96.69M |
|
$20.97M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.94 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-148.99M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-912.44% |
|
-912.44% |
|
-89.96% |
|
-912.44% |
|
$1.59 |
|
$-19.17 |
|
$-19.13 |
|